By
Drug Target Review2025-10-29T10:28:41
Scientists have identified an overactive brain cell type linked to schizophrenia-like symptoms in mice – a discovery that could lead to new, targeted treatments to prevent cognitive impairments.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2024-01-26T13:22:42
Sponsored by bit.bio
2023-05-10T11:18:16
Sponsored by Revvity
2023-03-03T14:06:14
Sponsored by Bio-Techne
2024-02-07T14:34:33
Sponsored by BellBrook Labs
Site powered by Webvision Cloud